The Center for Breakthrough Medicines (CBM) specializes in the development and manufacturing of advanced therapies, focusing on cell and gene therapies. Their comprehensive services encompass drug substance and drug product development across all phases of the product lifecycle, all conducted at a single site. CBM's capabilities include process development, analytical testing, and manufacturing of plasmid DNA, viral vectors, and cell therapies. They emphasize a fully integrated approach that accelerates the transition from research and development to commercialization, ensuring that clients can navigate the complexities of advanced therapy production efficiently.

CBM's process development strategies are tailored to enhance manufacturing efficiency and product quality, with a strong emphasis on Good Manufacturing Practice (GMP) compliance. Their facilities are equipped with advanced technology for viral vector production, including platforms for Adeno-Associated Virus (AAV), Lentivirus, and other novel vectors. Additionally, CBM offers extensive analytical services to support the development of drug products, ensuring compatibility, stability, and regulatory compliance. Their commitment to innovation and patient safety positions them as a leading partner in the rapidly evolving field of advanced therapies.

United States

Center for Breakthrough Medicines is an innovative cell and gene therapy organization focused on contract development and manufacturing organization located in the heart of “Cellicon Valley.”

Center for Breakthrough Medicines

Company Details